Co-colonization by multidrug-resistant bacteria in two Greek intensive care units

M Papadimitriou-Olivgeris1, I Spiliopoulou2, M Christofidou2

  • 1Division of Infectious Diseases, School of Medicine, University of Patras, 26504, Rion, Patras, Greece.

Insights

This study identified risk factors for co-colonization by KPC-Kp, VRE, and MRSA in ICUs. Colonization by one multidrug-resistant organism increases the risk of acquiring another, highlighting the need for infection control.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Intensive care units (ICUs) are high-risk environments for the emergence and spread of multidrug-resistant organisms (MDROs).
  • Co-colonization by KPC-producing Klebsiella pneumoniae (KPC-Kp), vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat to patient outcomes.

Purpose of the Study:

  • To identify risk factors associated with co-colonization by KPC-Kp, VRE, and MRSA upon ICU admission and during the ICU stay.
  • To investigate the relationship between colonization by different MDROs.

Main Methods:

  • Prospective study involving rectal and nasal sampling of 481 patients admitted to two Greek ICUs.
  • Weekly sampling during ICU stay, with microbial identification using standard methods and Vitek-2 technology.
  • Confirmation of specific resistance genes (blaKPC, vanA/vanB, mecA) via PCR.

Main Results:

  • Upon ICU admission, 12% were colonized by KPC-Kp, 13% by VRE, and 4% by MRSA.
  • KPC-Kp colonization was an independent risk factor for VRE colonization (OR 2.7 on admission, OR 7.4 during stay).
  • VRE colonization was a risk factor for KPC-Kp (OR 5.1 on admission) and MRSA (OR 3.5 on admission, OR 14.5 during stay) colonization.

Conclusions:

  • Colonization by one MDRO can promote colonization by another, suggesting a potential synergistic effect.
  • Co-morbidities, antibiotic administration, and prior KPC-Kp infection were associated with KPC-Kp and VRE co-colonization.
  • Effective infection control strategies are crucial to prevent co-colonization and subsequent infections in ICUs.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...